Quarter ended on June 30, 2025Data in Crores of INR
Revenue
₹ 24.67-0.45% from last year
Operating profits
₹ 7.96-8.19% from last year
Net income
₹ 3.45-25.88% from last year
Financial reports
Data is unavailable
INCOME STATEMENT
Data in Crores of INR
Data is unavailable
BALANCE SHEET
Data in Crores of INR
FY 2024
FY 2020
FY 2019
Net worth
122.10
42.20
33.82
Fixed assets
80.55
20.14
14.50
Debt
36.31
4.47
0.75
View detailed balance sheet
CASH FLOW
Data in Crores of INR
FY2024
FY2020
FY2019
Operating
30.45
4.59
-5.22
Investing
-33.01
-2.91
-0.08
Financing
9.84
-0.48
-0.18
Financial ratios
Profitability ratios
ROA24.08%
ROE34.22%
ROCE37.81%
EPS21.89%
Net profit margin22.33%
Operating profit margin34.7%
Dividend per share
Operational ratios
Quick ratio2.02%
Current ratio2.98%
Interest coverage63.85%
Assets turnover1.11%
Debt to equity0.3%
Valuation ratios
P/E ratio30.56%
P/B ratio4.5%
Dividend yield
EV/EBITDA
Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to antipsychotic antiseptic deprotonation reactions hyperlipidemia alzheimers and anti-viral.
Grow your wealth with more research recommendations